John Buscombe, Nuclear ... medullary thyroid cancer. Whole-body images performed 48 h after administration of 5.5GBq of 131 I in a patient presenting with disseminated metastatic papillary thyroid ...

The good news is that the risk for thyroid cancer linked to GLP-1 drugs appears low, but higher detections in the first year, ...

In this issue of The Lancet Diabetes & Endocrinology, Michelle M Chen and colleagues1 report their findings on trends in the incidence of thyroid cancer in the USA from 1975 to 2019. The authors show ...

The hypothalamic–pituitary–thyroid axis plays a crucial role in the pathogenesis, diagnosis, risk stratification, effectiveness of radioiodine therapy, and treatment response evaluation in epithelial ...

The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy, but risk is elevated in the first year of treatment, according to a ...

As cancer rates in the West, and globally, tack upwards due to lifestyle and environmental pollution, so does the need for the nuclear isotopes used in detecting those cancers in a medical setting.

the biggest driver is actually breast cancer followed by thyroid cancer," said Dr. Jennifer Molokwu, the Director of Cancer prevention at Texas Tech Physicians at El Paso. So what's going on?

A World Health Organization (WHO)-commissioned systematic review published in Environment International finds no association ...

I wasn’t prepared for what he told me next. “You have textbook thyroid cancer and it is really far spread into your lymph nodes.” I had delayed seeing a doctor because I thought I was ...

“Breast and thyroid cancer account for almost half of all cancer diagnoses in women younger than 50,” said Rebecca Siegel, lead author of the report and senior scientific director of ...